Ken Herrmann is Chair of the Scientific Advisory Board of Molecular Partners, which he joined in 2025. He is Professor of Nuclear Medicine at the University Hospital Essen, Section Editor of The Journal of Nuclear Medicine, and previous Chair of the European Association of Nuclear Medicine (EANM) Oncology & Theranostics Committee. He was previously Adjunct Professor at the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles (UCLA) and Vice Chair of the Department of Nuclear Medicine at University Hospital Würzburg. Ken completed his residency in nuclear medicine at the Technical University Munich, a fellowship at Hokkaido University and earned his M.D. from Humboldt University Berlin and MBA from the University of Zurich.